July 1, 2019
The Ministry of Health, Labor and Welfare (MHLW) on June 27 granted orphan drug designation for Bayer Yakuhin’s age-related macular degeneration treatment Eylea (aflibercept) for the treatment of neovascular glaucoma. The drug is now in PIII development in Japan for...read more